The Gaithersburg-based biotech just received approval to introduce its anthrax vaccine in five European countries, a move that brings the possibility of a new and important revenue stream.

The biotech halted the trial while it investigates ... a genetic blood disorder that causes potentially life-threatening bouts of pain, received the experimental treatment, called nula-cel ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs from fellow British biotech ... will receive 19% of Mosaic ...

XyloCor Therapeutics Inc., a Wayne gene therapy company, received $67.5 million from investors to support Phase 2 trials of a treatment designed to grow new blood vessels in the heart, XyloCor ...

A small clinical trial has found no pattern of improvements in lung function in cystic fibrosis patients who received Translate Bio’s mRNA prospect MRT5005. The setback, which sent the biotech ...

CAR-T specialist Legend Biotech has reportedly received a takeover bid and has ... scoop up Biohaven Pharma’s CGRP inhibitor portfolio just months after forming a collaboration on the latter ...